Navigation Links
Blue Cross Blue Shield of North Carolina Implements Aggressive Generic Medication Campaign
Date:4/16/2008

The Plan Moves More than 40 Tier 3 Drugs for Chronic Diseases to Tier 2,

According to a New Report from HealthLeaders-InterStudy

NASHVILLE, Tenn., April 16 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, reports that Blue Cross and Blue Shield of North Carolina has begun an aggressive generic medication campaign as of January 2008 in which it waives the copayment on all generic drugs that treat congestive heart failure, high blood pressure, high cholesterol and diabetes. According to the new report entitled Blue Profiler: Blue Cross and Blue Shield of North Carolina, the campaign, called Medication Dedication, is the plan's attempt to encourage members to take prescription drugs as directed and to make the overall cost of drugs more affordable.

"In 2007, Blue Cross and Blue Shield of North Carolina's generic utilization rate was higher than its two major competitors, UnitedHealthcare and CIGNA Healthcare," said Heather Wicks, analyst at HealthLeaders- InterStudy. "The Blue Plan's rate was 58 percent in 2007, up from 46.8 percent in 2004."

The report also finds that Blue Cross and Blue Shield of North Carolina has moved more than 40 drugs to treat chronic diseases from Tier 3 to Tier 2 as part of its Medication Dedication program. For example, Tier 3 drugs to treat diabetes moved to Tier 2 status include Byetta, Fortamet, Glucagen, Glumetza, Glyset, Prandin, Riomet, Starlit and Symlin.

"Blue Cross Blue Shield of North Carolina had been more aggressive than competitors CIGNA Healthcare and UnitedHealthcare in the placement of more expensive brand-name drugs in tiers requiring higher copays," continued Ms. Wicks. "However, the decision to move more drugs to lower tiers in 2008 should put Blue Cross Blue Shield of North Carolina more in line with other payers."

Blue Profiler: Blue Cross and Blue Shield of North Carolina is one of 15 2008 Blue Profiler reports on the nation's largest nonprofit Blue Cross Blue Shield plans, which together insure more than 50 million people.

About Blue Profiler

Blue Profiler offers the most comprehensive analysis of the nonprofit Blue Cross Blue Shield plans. Each report includes an individual nonprofit Blue plan and includes valuable analysis that will allow companies to more effectively partner with these dominant organizations. Each report includes information on:

-- Competitive analysis

-- Enrollment trends

-- Company-wide financials

-- HMO financials

-- Consumer-driven products

-- Medicare strategy

-- Pharmacy

-- Disease Management

About HealthLeaders-InterStudy

HealthLeaders-InterStudy (http://www.hl-isy.com) is the authoritative source for managed care data and analysis. HealthLeaders-InterStudy is a Decision Resources, Inc. company.

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders.

For more information, contact:

Elizabeth Marshall

Decision Resources, Inc.

781-296-2563

emarshall@dresources.com


'/>"/>
SOURCE HealthLeaders-InterStudy
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Using HR Performance Metrics to Drive Costs Down Across HR Functions
2. Cedar Point to Host 17th Annual Red Cross Miniature Golf Event
3. Two Men to Walk Across America for Autism Aid, Awareness, and Loving Memory of Young Boy
4. Polar Introduces Cost-Effective Solution to Reduce Heart Rate Data Cross-Talk
5. Kids With Cell Phones Not as Safe Crossing Streets
6. Blue Cross and Blue Shield of Oklahoma Launches an Integrated Medical-Dental Health Program
7. Anthem Blue Cross Tackles Childhood Obesity in California Through Free BMI Workshops for Pediatric and Family Medicine Health Care Providers
8. Business Leader, Nonprofit Volunteer to Head the American Red Cross
9. Researchers Able to Continue their Work to Help Patients Thanks to McDevitt Excellence in Research Awards from Blue Cross Blue Shield of Michigan Foundation
10. Daniel Corcoran named President of Anthem Blue Cross and Blue Shield in Maine
11. Partnership for Prescription Assistance Celebrates Three Year Anniversary; Helps Nearly 5 Million Uninsured Patients Across United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... , ... “I Forgive You”: a fine examination of how God handles sin, including how ... published author, Stephen Miller, who, for over ten long years has been waiting to release ... Trinidad and Tobago, he has been serving the Lord for over twenty years, and he ...
(Date:1/20/2017)... ... ... in Suffolk”: a story of love, secrets, and mystery. “Christmas in Suffolk” is ... works in a daycare and looks for inspiration in the local coffee shop as ... Seymour’s new book is an adventure of love and secrets. , After ...
(Date:1/20/2017)... , ... January 20, 2017 , ... “Knowledge is God’s ... guided by faith. “Knowledge is God’s Lighthouse” is the creation of published author, Gene ... novels, and poetry collections. , “I have been writing since high school and ...
(Date:1/20/2017)... ... January 20, 2017 , ... “God's Miracle Man: Against All ... is the creation of published author, Keith C. A. Tucker, son of Minister Delores ... World Outreach pastured by Reverend Mark Hardy , “While sitting up in bed, I ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... On-demand E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, ... Aerolib`s successful education methodology of Disease Specific Documentation Improvement. , The Aerolib ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... YORK , Jan. 19, 2017 Report ... ... 2016-2026: Opportunities for Leading Companies – our new study ... report discusses issues and events affecting the Alzheimer,s disease ... analyses to answer these key questions: - How is ...
(Date:1/19/2017)... -- Stealth BioTherapeutics Inc. ( Stealth ), a clinical-stage biopharmaceutical ... new additions to its senior leadership team: W. ... Daniel Geffken as interim Chief Financial Officer. ... Pharm.D. has been promoted to Chief Clinical Development Officer. ... and Daniel to our management team, as both will ...
(Date:1/19/2017)... Calif. , Jan. 19, 2017 Accuray ... its CyberKnife® and TomoTherapy® Systems continue to set the ... received the highest composite overall user satisfaction rating among ... the Q4 2016 MD Buyline Market Intelligence Briefing™. The ... the highest composite ratings among industry peers for 11 ...
Breaking Medicine Technology: